Founded in 2008 by Jeffrey A Ferrel in New York, Athyrium Capital Management focuses on investing in healthcare companies that provide biopharmaceuticals, molecular diagnostics for cancer treatment, and physician services. With over $1.7 billion of committed capital, the firm offers creative financing solutions to meet companies' capital needs and has substantial investment experience across various asset classes in the healthcare sector. Their investors include public and corporate pension funds, insurance companies, family offices, and sovereign wealth funds.